Opioid use disorder is a chronic medical condition, not a moral failing — and it responds to treatment the same way other chronic conditions do: with a combination of medication, support, and consistent care. Medication-assisted treatment for opioid use disorder in Chandler, Arizona gives people a evidence-based path toward recovery, reducing cravings and withdrawal symptoms while lowering the risk of relapse and overdose. This guide explains how MAT works, what the research shows, and what to expect from treatment.
What Is Medication-Assisted Treatment (MAT)?
Medication-assisted treatment combines FDA-approved medications with counseling and behavioral support to treat opioid use disorder. Rather than relying on willpower alone to manage withdrawal and cravings, MAT addresses the physical dependence on opioids directly, giving people the stability needed to engage in therapy, rebuild their lives, and work toward long-term recovery.
It’s worth emphasizing that opioid use disorder changes the brain’s chemistry in ways that make quitting through sheer determination alone extremely difficult for most people — not because of a lack of willpower, but because of how deeply opioids affect the brain’s reward and stress-response systems. MAT works by directly addressing these biological changes, which is why it consistently outperforms abstinence-only approaches in clinical research.
Understanding the Scope of the Opioid Crisis
The opioid epidemic remains one of the most serious public health crises in the country, even as recent data shows encouraging progress. According to KFF’s analysis of CDC data, opioid overdose deaths fell from 79,358 in 2023 to 54,045 in 2024 — a meaningful decline, but still a substantial public health burden.
- Despite the effectiveness of MAT, a CDC report published in MMWR found that in 2022, among U.S. adults who needed treatment for opioid use disorder, only 25% received the recommended medications — meaning the vast majority of people who could benefit from MAT are not receiving it.
- The same CDC research emphasizes that medications for opioid use disorder — particularly buprenorphine and methadone — substantially reduce overdose-related and overall mortality, underscoring why expanding access to MAT is a public health priority.
These numbers highlight both the urgency of the opioid crisis and the importance of making evidence-based treatment more accessible and less stigmatized.
What Happens During Opioid Withdrawal Without Treatment
Understanding why MAT matters starts with understanding what withdrawal looks like without medical support. Opioid withdrawal can include intense symptoms such as muscle aches, nausea, vomiting, diarrhea, anxiety, insomnia, and powerful drug cravings. While opioid withdrawal is rarely life-threatening on its own, it is often severe enough that people return to opioid use simply to stop the withdrawal symptoms — even when they genuinely want to quit. This is one of the key reasons unassisted “cold turkey” attempts have such high relapse rates, and why medically supervised treatment offers a meaningfully different path forward.
Signs You or a Loved One May Need MAT
Recognizing opioid use disorder early can make treatment more effective and reduce the risk of overdose. Warning signs include:
- Taking opioids in larger amounts or for longer than intended
- Unsuccessful efforts to cut down or control opioid use
- Cravings or a strong urge to use opioids
- Continuing to use despite negative effects on relationships, work, or health
- Experiencing withdrawal symptoms when not using
- Needing increasing amounts to achieve the same effect (tolerance)
If several of these apply to you or someone you care about, reaching out to a provider for an assessment is a strong first step — you don’t need to wait for a crisis to seek help.
How MAT Works: Medications Used in Treatment
Several FDA-approved medications are used in MAT, each working somewhat differently to support recovery:
- Buprenorphine: Partially activates opioid receptors, reducing cravings and withdrawal symptoms while carrying a lower risk of misuse than full opioid agonists.
- Naltrexone: Blocks opioid receptors entirely, preventing opioids from producing their typical effects, which can help reduce the temptation to use.
- Methadone: A longer-acting medication typically administered through specialized clinics, used to reduce cravings and withdrawal symptoms in more severe cases.
Your provider will help determine which medication is the best fit based on your history, the severity of your opioid use disorder, and your personal recovery goals.
Why MAT Is Considered the Gold Standard for Opioid Use Disorder
Decades of research support MAT as the most effective treatment approach for opioid use disorder. By stabilizing brain chemistry and reducing the physical grip of withdrawal and cravings, MAT allows people to engage more fully in counseling, rebuild relationships, and return to work or school — outcomes that are much harder to achieve when someone is cycling through withdrawal and relapse without medical support.
Major medical organizations, including the American Society of Addiction Medicine and the Substance Abuse and Mental Health Services Administration, recognize MAT as the standard of care for opioid use disorder — not an alternative or last-resort option. This reflects a broader shift in how addiction medicine understands opioid use disorder: as a chronic, treatable medical condition rooted in changes to brain chemistry, rather than simply a matter of choice or willpower. Treating it accordingly, with appropriate medication and ongoing medical support, consistently produces better outcomes than abstinence-only approaches.
What to Expect During MAT at Ada Psychiatry
Ada Psychiatry provides medication-assisted treatment as part of a comprehensive approach to opioid addiction recovery. Treatment typically includes:
- A thorough assessment of your substance use history, physical health, and treatment goals
- A personalized medication plan, prescribed and monitored by trained providers
- Regular follow-up appointments to adjust dosing and monitor progress
- Supportive psychotherapy to address the underlying factors contributing to substance use
- Coordination with other providers as needed for a comprehensive recovery plan
Per DEA guidelines and regulations, controlled substances used in MAT are prescribed on a case-by-case basis, and availability may vary between in-person and virtual care settings.
Combining MAT with Counseling and Support
Medication addresses the physical side of opioid use disorder, but lasting recovery usually also involves addressing the psychological and social factors that contribute to substance use. Supportive psychotherapy helps people build coping skills, process underlying trauma or stress, and develop healthier patterns for managing life’s challenges — working alongside medication rather than replacing it.
Building a Full Recovery Plan Beyond Medication
While medication addresses the physical foundation of opioid use disorder, lasting recovery tends to be strongest when it’s part of a broader plan:
- Individual or group counseling to address triggers, coping skills, and underlying stressors
- Support networks, whether through peer recovery groups, family involvement, or community resources
- Treatment for any co-occurring mental health conditions, such as depression, anxiety, or trauma, which frequently accompany substance use disorders
- Practical support for rebuilding stability in areas like employment, housing, and relationships
A comprehensive care team can help coordinate these different pieces so that recovery feels supported from multiple directions, not just medically managed.
Addressing Stigma Around MAT
One of the biggest barriers to MAT isn’t access — it’s stigma. Some people mistakenly believe MAT simply “replaces one addiction with another.” In reality, MAT medications are used under medical supervision to stabilize brain chemistry disrupted by opioid use disorder, similar to how insulin is used to manage diabetes. Reframing MAT as legitimate medical treatment, rather than a moral shortcut, is an important step toward getting more people the care they need.
Family members and friends can play an important role in reducing this stigma as well, by educating themselves about how MAT works and offering encouragement rather than judgment. Recovery is rarely a straight line, and having a supportive environment — free of shame or unrealistic expectations — measurably improves the odds of long-term success.
Frequently Asked Questions
1. How long does medication-assisted treatment for opioid use disorder last?
Treatment length varies by individual. Some people use MAT for several months during active recovery, while others benefit from longer-term maintenance treatment. Your provider will work with you to determine the right timeline based on your progress and goals.
2. Is medication-assisted treatment the same as replacing one addiction with another?
No. MAT medications are used under medical supervision to stabilize brain chemistry and reduce cravings and withdrawal, allowing people to function normally and engage in recovery — unlike the compulsive, harmful patterns associated with active opioid use disorder.
3. Can I receive medication-assisted treatment through virtual appointments?
Ada Psychiatry offers in-person and virtual psychiatric care, though the prescribing of certain controlled substances is handled on a case-by-case basis in accordance with DEA guidelines, and may not be available for all virtual-only states. Contact our office to discuss your specific situation and location.
4. Will insurance cover medication-assisted treatment?
Ada Psychiatry is in-network with several major insurers, including United Healthcare/Optum/Oscar Health, Cigna, Aetna, and Blue Cross Blue Shield of Arizona. We also provide self-pay fee information for those without in-network coverage.
5. What happens if I relapse while on MAT?
Relapse doesn’t mean treatment has failed — opioid use disorder is a chronic condition, and setbacks can be part of the recovery process. If a relapse occurs, it’s important to reach out to your provider right away to reassess your treatment plan and safety, rather than avoiding care out of shame or fear.
Take the First Step Toward Recovery
If you or a loved one is struggling with opioid use disorder, medication-assisted treatment in Chandler, Arizona can help. Ada Psychiatry provides compassionate, evidence-based care to support your recovery. Book an appointment online, or contact us with any questions.
Ada Psychiatry | 1820 E Ray Road, STE A110, Chandler, Arizona 85225 | Phone: 480-526-9292
